메뉴 건너뛰기




Volumn 34, Issue SUPPL2, 2012, Pages 125-148

New molecular targets for PET and SPECT imaging in neurodegenerative diseases

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID IMAGING TRACER; AMYLOID PRECURSOR PROTEIN; ANTERIOR PHARYNX DEFECTIVE 1 PROTEIN; BETA SECRETASE 1; BIOLOGICAL MARKER; CARBON 11; DISINTEGRIN; FLORBETABEN; FLUORINE 18; FLUTEMETAMOL F 18; HEAT SHOCK PROTEIN; IODINE 123; LEWY BODY TRACER; MULTIDRUG RESISTANCE PROTEIN; NICASTRIN; PHENSERINE; PITTSBURGH COMPOUND B; PRESENILIN; PRESENILIN 2; RHENIUM; TAU IMAGING TRACER; TAU PROTEIN; TECHNETIUM; TECHNETIUM 99M; TRACER; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 84872909152     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbp.2012.07.002     Document Type: Article
Times cited : (28)

References (117)
  • 2
    • 78650394438 scopus 로고    scopus 로고
    • Molecular tracers for the PET and SPECT imaging of disease
    • Pimlott SL, Sutherland A. Molecular tracers for the PET and SPECT imaging of disease. Chem Soc Rev. 2011;40(1):149-62.
    • (2011) Chem Soc Rev , vol.40 , Issue.1 , pp. 149-162
    • Pimlott, S.L.1    Sutherland, A.2
  • 3
    • 0036392074 scopus 로고    scopus 로고
    • Positron emission tomography: Imaging and quantification of neurotransporter availability
    • Laruelle M, Slifstein M, Huang Y. Positron emission tomography: imaging and quantification of neurotransporter availability. Methods. 2002;27(3):287-99.
    • (2002) Methods , vol.27 , Issue.3 , pp. 287-299
    • Laruelle, M.1    Slifstein, M.2    Huang, Y.3
  • 4
    • 77956189401 scopus 로고    scopus 로고
    • Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease
    • Någren K, Halldin C, Rinne JO. Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2010;37(8):1575-93.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , Issue.8 , pp. 1575-1593
    • Någren, K.1    Halldin, C.2    Rinne, J.O.3
  • 5
    • 36749062430 scopus 로고    scopus 로고
    • Molecular and cellular mechanisms for Alzheimer's disease: Understanding APP metabolism
    • Zhang Y-wu, Xu H. Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism. Curr Mol Med. 2007;7(7):687-96.
    • (2007) Curr Mol Med , vol.7 , Issue.7 , pp. 687-696
    • Y-Wu, Z.1    Xu, H.2
  • 6
    • 10744232413 scopus 로고    scopus 로고
    • Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
    • Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55(3):306-19.
    • (2004) Ann Neurol , vol.55 , Issue.3 , pp. 306-319
    • Klunk, W.E.1    Engler, H.2    Nordberg, A.3    Wang, Y.4    Blomqvist, G.5    Holt, D.P.6
  • 9
    • 66549106850 scopus 로고    scopus 로고
    • Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease
    • Jack CR, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain. 2009;132(Pt 5):1355-65.
    • (2009) Brain , vol.132 , Issue.PART 5 , pp. 1355-1365
    • Jack, C.R.1    Lowe, V.J.2    Weigand, S.D.3    Wiste, H.J.4    Senjem, M.L.5    Knopman, D.S.6
  • 10
    • 33749506795 scopus 로고    scopus 로고
    • Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
    • Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain. 2006;129(Pt 11):2856-66.
    • (2006) Brain , vol.129 , Issue.PART 11 , pp. 2856-2866
    • Engler, H.1    Forsberg, A.2    Almkvist, O.3    Blomquist, G.4    Larsson, E.5    Savitcheva, I.6
  • 13
    • 4544335597 scopus 로고    scopus 로고
    • Mild cognitive impairment as a diagnostic entity
    • Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183-94.
    • (2004) J Intern Med , vol.256 , Issue.3 , pp. 183-194
    • Petersen, R.C.1
  • 15
    • 49349092320 scopus 로고    scopus 로고
    • PET imaging of amyloid deposition in patients with mild cognitive impairment
    • Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol aging. 2008;29(10):1456-65.
    • (2008) Neurobiol Aging , vol.29 , Issue.10 , pp. 1456-1465
    • Forsberg, A.1    Engler, H.2    Almkvist, O.3    Blomquist, G.4    Hagman, G.5    Wall, A.6
  • 16
    • 70349582720 scopus 로고    scopus 로고
    • Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study
    • Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Någren K et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology. 2009;73(10):754-60.
    • (2009) Neurology , vol.73 , Issue.10 , pp. 754-760
    • Okello, A.1    Koivunen, J.2    Edison, P.3    Archer, H.A.4    Turkheimer, F.E.5    Någren, K.6
  • 18
  • 20
    • 41149127264 scopus 로고    scopus 로고
    • Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease
    • Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H et al. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Ann Neurol. 2008;63(5):621-31.
    • (2008) Ann Neurol , vol.63 , Issue.5 , pp. 621-631
    • Kadir, A.1    Andreasen, N.2    Almkvist, O.3    Wall, A.4    Forsberg, A.5    Engler, H.6
  • 21
    • 77249145936 scopus 로고    scopus 로고
    • 18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: A miniperspective
    • Kung HF, Choi SR, Qu W, Zhang W, Skovronsky D. 18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective. J Med Chem. 2010;53(3):933-41.
    • (2010) J Med Chem , vol.53 , Issue.3 , pp. 933-941
    • Kung, H.F.1    Choi, S.R.2    Qu, W.3    Zhang W.Skovronsky, D.4
  • 22
    • 77956384880 scopus 로고    scopus 로고
    • 8F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
    • Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol. 2010;68(3):319-29.
    • (2010) Ann Neurol , vol.68 , Issue.3 , pp. 319-329
    • Vandenberghe, R.1    van Laere, K.2    Ivanoiu, A.3    Salmon, E.4    Bastin, C.5    Triau, E.6
  • 23
    • 77953937194 scopus 로고    scopus 로고
    • In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)
    • Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med. 2010;51(6):913-20.
    • (2010) J Nucl Med , vol.51 , Issue.6 , pp. 913-920
    • Wong, D.F.1    Rosenberg, P.B.2    Zhou, Y.3    Kumar, A.4    Raymont, V.5    Ravert, H.T.6
  • 24
    • 80055040100 scopus 로고    scopus 로고
    • Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET
    • Barthel H, Sabri O. Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET. J Alzheimers Dis. 2011;26(Suppl 3):117-21.
    • (2011) J Alzheimers Dis , vol.26 , Issue.SUPPL. 3 , pp. 117-121
    • Barthel, H.1    Sabri, O.2
  • 25
    • 84864535821 scopus 로고    scopus 로고
    • FDA Approves 18F-Florbetapir PET Agent
    • FDA Approves 18F-Florbetapir PET Agent. J Nucl Med. 2012;53(6):15N.
    • (2012) J Nucl Med , vol.53 , Issue.6
  • 26
    • 78751647972 scopus 로고    scopus 로고
    • 99mTc- and Re-labeled 6-dialkylamino-2-naphthylethylidene derivatives as imaging probes for β-amyloid plaques
    • Cui M, Tang R, Li Z, Ren H, Liu B. 99mTc- and Re-labeled 6-dialkylamino-2-naphthylethylidene derivatives as imaging probes for β-amyloid plaques. Bioorg Med Chem Lett. 2011;21(3):1064-8.
    • (2011) Bioorg Med Chem Lett , vol.21 , Issue.3 , pp. 1064-1068
    • Cui, M.1    Tang, R.2    Li, Z.3    Ren, H.4    Liu, B.5
  • 27
    • 0026597063 scopus 로고
    • Alzheimer's disease: The amyloid cascade hypothesis
    • Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184-5.
    • (1992) Science , vol.256 , Issue.5054 , pp. 184-185
    • Hardy, J.A.1    Higgins, G.A.2
  • 28
    • 0025908356 scopus 로고
    • The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
    • Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41(4):479-86.
    • (1991) Neurology , vol.41 , Issue.4 , pp. 479-486
    • Mirra, S.S.1    Heyman, A.2    McKeel, D.3    Sumi, S.M.4    Crain, B.J.5    Brownlee, L.M.6
  • 29
    • 0026740795 scopus 로고
    • Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
    • Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992;42(3 Pt 1):631-9.
    • (1992) Neurology , vol.42 , Issue.3 PART 1 , pp. 631-639
    • Arriagada, P.V.1    Growdon, J.H.2    Hedley-Whyte, E.T.3    Hyman, B.T.4
  • 30
    • 0344653664 scopus 로고    scopus 로고
    • Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
    • Gómez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol. 1997;41(1):17-24.
    • (1997) Ann Neurol , vol.41 , Issue.1 , pp. 17-24
    • Gómez-Isla, T.1    Hollister, R.2    West, H.3    Mui, S.4    Growdon, J.H.5    Petersen, R.C.6
  • 32
    • 84859482077 scopus 로고    scopus 로고
    • Molecular Approaches to the Treatment, Prophylaxis, and Diagnosis of Alzheimer's Disease: Novel PET/ SPECT Imaging Probes for Diagnosis of Alzheimer's Disease
    • Ono M, Saji H. Molecular Approaches to the Treatment, Prophylaxis, and Diagnosis of Alzheimer's Disease: Novel PET/ SPECT Imaging Probes for Diagnosis of Alzheimer's Disease. J Pharmacol Sci. 2012;344(338):338-44.
    • (2012) J Pharmacol Sci , vol.344 , Issue.338 , pp. 338-344
    • Ono, M.1    Saji, H.2
  • 33
    • 0035893245 scopus 로고    scopus 로고
    • Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease
    • Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A et al. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci. 2001;21(24):RC189.
    • (2001) J Neurosci , vol.21 , Issue.24
    • Agdeppa, E.D.1    Kepe, V.2    Liu, J.3    Flores-Torres, S.4    Satyamurthy, N.5    Petric, A.6
  • 34
    • 84903202261 scopus 로고    scopus 로고
    • Localization of neurofibrillary tangles and betaamyloid plaques in the brains of living patients with Alzheimer disease
    • Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P et al. Localization of neurofibrillary tangles and betaamyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry. 2002;10(1):24-35.
    • (2002) Am J Geriatr Psychiatry , vol.10 , Issue.1 , pp. 24-35
    • Shoghi-Jadid, K.1    Small, G.W.2    Agdeppa, E.D.3    Kepe, V.4    Ercoli, L.M.5    Siddarth, P.6
  • 35
    • 40149109154 scopus 로고    scopus 로고
    • Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene]
    • Velasco A, Fraser G, Delobel P, Ghetti B, Lavenir I, Goedert M. Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene]. FEBS lett. 2008;582(6):901-6.
    • (2008) FEBS Lett , vol.582 , Issue.6 , pp. 901-906
    • Velasco, A.1    Fraser, G.2    Delobel, P.3    Ghetti, B.4    Lavenir, I.5    Goedert, M.6
  • 39
    • 28044460038 scopus 로고    scopus 로고
    • Quinoline and benzimidazole derivatives: Candidate probes for in vivo imaging of tau pathology in Alzheimer's disease
    • Okamura N, Suemoto T, Furumoto S, Suzuki M, Shimadzu H, Akatsu H et al. Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease. J Neurosci. 2005;25(47):10857-62.
    • (2005) J Neurosci , vol.25 , Issue.47 , pp. 10857-10862
    • Okamura, N.1    Suemoto, T.2    Furumoto, S.3    Suzuki, M.4    Shimadzu, H.5    Akatsu, H.6
  • 41
    • 77954315712 scopus 로고    scopus 로고
    • Development of dual functional SPECT/fluorescent probes for imaging cerebral beta-amyloid plaques
    • Ono M, Ishikawa M, Kimura H, Hayashi S, Matsumura K, Watanabe H et al. Development of dual functional SPECT/fluorescent probes for imaging cerebral beta-amyloid plaques. Bioorg Med Chem Lett. 2010;20(13):3885-8.
    • (2010) Bioorg Med Chem Lett , vol.20 , Issue.13 , pp. 3885-3888
    • Ono, M.1    Ishikawa, M.2    Kimura, H.3    Hayashi, S.4    Matsumura, K.5    Watanabe, H.6
  • 43
    • 81455139926 scopus 로고    scopus 로고
    • Interaction between α-synuclein and other proteins in neurodegenerative disorders
    • Jellinger KA. Interaction between α-synuclein and other proteins in neurodegenerative disorders. ScientificWorldJournal. 2011;11:1893-907.
    • (2011) ScientificWorldJournal , vol.11 , pp. 1893-1907
    • Jellinger, K.A.1
  • 44
    • 63449093494 scopus 로고    scopus 로고
    • Alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity
    • Liu G, Zhang C, Yin J, Li X, Cheng F, Li Y et al. alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci lett. 2009;454(3):187-92.
    • (2009) Neurosci Lett , vol.454 , Issue.3 , pp. 187-192
    • Liu, G.1    Zhang, C.2    Yin, J.3    Li, X.4    Cheng, F.5    Li, Y.6
  • 45
    • 84866918574 scopus 로고    scopus 로고
    • From α-synuclein to synaptic dysfunctions: New insights into the pathophysiology of Parkinson's disease
    • Available at, [cited 2012 Jun 25]
    • Bellucci A, Zaltieri M, Navarria L, Grigoletto J, Missale C, Spano P. From α-synuclein to synaptic dysfunctions: New insights into the pathophysiology of Parkinson's disease. Brain Res [Available at: http://www.ncbi.nlm.nih.gov/pubmed/22560500]. 2012 [cited 2012 Jun 25].
    • (2012) Brain Res
    • Bellucci, A.1    Zaltieri, M.2    Navarria, L.3    Grigoletto, J.4    Missale, C.5    Spano, P.6
  • 47
    • 4644249092 scopus 로고    scopus 로고
    • Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein
    • discussion 443-9
    • Alim MA, Ma Q-L, Takeda K, Aizawa T, Matsubara M, Nakamura M et al. Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein. J Alzheimers Dis. 2004;6(4):435-42 [discussion 443-9].
    • (2004) J Alzheimers Dis , vol.6 , Issue.4 , pp. 435-442
    • Alim, M.A.1    Ma, Q.-L.2    Takeda, K.3    Aizawa, T.4    Matsubara, M.5    Nakamura, M.6
  • 48
    • 33746533924 scopus 로고    scopus 로고
    • Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
    • Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science. 2006;313(5785):324-8.
    • (2006) Science , vol.313 , Issue.5785 , pp. 324-328
    • Cooper, A.A.1    Gitler, A.D.2    Cashikar, A.3    Haynes, C.M.4    Hill, K.J.5    Bhullar, B.6
  • 49
    • 34548620297 scopus 로고    scopus 로고
    • Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation
    • Uversky VN. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. J Neurochem. 2007;103(1):17-37.
    • (2007) J Neurochem , vol.103 , Issue.1 , pp. 17-37
    • Uversky, V.N.1
  • 50
    • 34248579112 scopus 로고    scopus 로고
    • A novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients
    • 2-(2-[2-Dimethylaminothiazol-5-yl] ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole
    • Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M et al. 2-(2-[2-Dimethylaminothiazol-5-yl] ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agentfor in vivo detection of dense amyloid plaques in Alzheimer's disease patients. J Nucl Med. 2007;48(4):553-61.
    • (2007) J Nucl Med , vol.48 , Issue.4 , pp. 553-561
    • Kudo, Y.1    Okamura, N.2    Furumoto, S.3    Tashiro, M.4    Furukawa K.Maruyama, M.5
  • 52
    • 77952982672 scopus 로고    scopus 로고
    • In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy
    • Kikuchi A, Takeda A, Okamura N, Tashiro M, Hasegawa T, Furumoto S et al. In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy. Brain. 2010;133(Pt 6):1772-8.
    • (2010) Brain , vol.133 , Issue.PART 6 , pp. 1772-1778
    • Kikuchi, A.1    Takeda, A.2    Okamura, N.3    Tashiro, M.4    Hasegawa, T.5    Furumoto, S.6
  • 53
  • 54
    • 42649115741 scopus 로고    scopus 로고
    • Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair
    • Chen M-K, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008;118(1):1-17.
    • (2008) Pharmacol Ther , vol.118 , Issue.1 , pp. 1-17
    • Chen, M.-K.1    Guilarte, T.R.2
  • 55
    • 13144258735 scopus 로고    scopus 로고
    • Microglial activation and dopamine terminal loss in early Parkinson's disease
    • Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T et al. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol. 2005;57(2):168-75.
    • (2005) Ann Neurol , vol.57 , Issue.2 , pp. 168-175
    • Ouchi, Y.1    Yoshikawa, E.2    Sekine, Y.3    Futatsubashi, M.4    Kanno, T.5    Ogusu, T.6
  • 56
    • 79551531674 scopus 로고    scopus 로고
    • In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease
    • Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y et al. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2011;38(2):343-51.
    • (2011) Eur J Nucl Med Mol Imaging , vol.38 , Issue.2 , pp. 343-351
    • Yokokura, M.1    Mori, N.2    Yagi, S.3    Yoshikawa, E.4    Kikuchi, M.5    Yoshihara, Y.6
  • 58
    • 9644254411 scopus 로고    scopus 로고
    • In vivo detection of microglial activation in frontotemporal dementia
    • Cagnin A, Rossor M, Sampson EL, Mackinnon T, Banati RB. In vivo detection of microglial activation in frontotemporal dementia. Ann Neurol. 2004;56(6):894-7.
    • (2004) Ann Neurol , vol.56 , Issue.6 , pp. 894-897
    • Cagnin, A.1    Rossor, M.2    Sampson, E.L.3    Mackinnon, T.4    Banati, R.B.5
  • 59
    • 51149120624 scopus 로고    scopus 로고
    • Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice
    • Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci. 2008;28(33):8354-60.
    • (2008) J Neurosci , vol.28 , Issue.33 , pp. 8354-8360
    • Hickman, S.E.1    Allison, E.K.2    El Khoury, J.3
  • 60
    • 67649101348 scopus 로고    scopus 로고
    • Imaging microglial activation during neuroinflammation and Alzheimer's disease
    • Venneti S, Wiley CA, Kofler J. Imaging microglial activation during neuroinflammation and Alzheimer's disease. J Neuroimmune Pharmacol. 2009;4(2):227-43.
    • (2009) J Neuroimmune Pharmacol , vol.4 , Issue.2 , pp. 227-243
    • Venneti, S.1    Wiley, C.A.2    Kofler, J.3
  • 61
    • 84865624449 scopus 로고    scopus 로고
    • Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases
    • Ching ASC, Kuhnast B, Damont A, Roeda D, Tavitian B, Dollé F. Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases. Insights Imaging. 2011;3(1):111-9.
    • (2011) Insights Imaging , vol.3 , Issue.1 , pp. 111-119
    • Ching, A.S.C.1    Kuhnast, B.2    Damont, A.3    Roeda, D.4    Tavitian, B.5    Dollé, F.6
  • 63
    • 34248529814 scopus 로고    scopus 로고
    • A novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation
    • 11C-DPA-713
    • Boutin H, Chauveau F, Thominiaux C, Grégoire M-C, James ML, Trebossen R, et al. 11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation. J Nucl Med. 2007;48(4):573-81.
    • (2007) J Nucl Med , vol.48 , Issue.4 , pp. 573-581
    • Boutin, H.1    Chauveau, F.2    Thominiaux, C.3    Grégoire, M.-C.4    James M.L.Trebossen, R.5
  • 64
    • 77952093172 scopus 로고    scopus 로고
    • In vivo imaging of neuroinflammation: A comparative study between [(18)F]PBR111, [ (11)C]CLINME and [ (11)C] PK11195 in an acute rodent model
    • Van Camp N, Boisgard R, Kuhnast B, Thézé B, Viel T, Grégoire M-C, et al. In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [ (11)C]CLINME and [ (11)C] PK11195 in an acute rodent model. Eur J Nucl Med Mol Imaging. 2010;37(5):962-72.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , Issue.5 , pp. 962-972
    • van Camp, N.1    Boisgard, R.2    Kuhnast, B.3    Thézé, B.4    Viel, T.5    Grégoire, M.-C.6
  • 66
    • 84863022896 scopus 로고    scopus 로고
    • Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide
    • Tang D, Hight MR, McKinley ET, Fu A, Buck JR, Smith RA et al. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide. J Nucl Med. 2012;53(2):287-94.
    • (2012) J Nucl Med , vol.53 , Issue.2 , pp. 287-294
    • Tang, D.1    Hight, M.R.2    McKinley, E.T.3    Fu, A.4    Buck, J.R.5    Smith, R.A.6
  • 67
    • 84862581540 scopus 로고    scopus 로고
    • The translocator protein ligand [(18)F]DPA-714 images glioma and activated microglia in vivo
    • Winkeler A, Boisgard R, Awde AR, Dubois A, Thézé B, Zheng J et al. The translocator protein ligand [(18)F]DPA-714 images glioma and activated microglia in vivo. Eur J Nucl Med Mol Imaging. 2012;39(5):811-23.
    • (2012) Eur J Nucl Med Mol Imaging , vol.39 , Issue.5 , pp. 811-823
    • Winkeler, A.1    Boisgard, R.2    Awde, A.R.3    Dubois, A.4    Thézé, B.5    Zheng, J.6
  • 70
    • 0032799421 scopus 로고    scopus 로고
    • Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands
    • Lalies MD, Hibell A, Hudson AL, Nutt DJ. Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands. Ann N Y Acad Sci. 1999;881:114-7.
    • (1999) Ann N Y Acad Sci , vol.881 , pp. 114-117
    • Lalies, M.D.1    Hibell, A.2    Hudson, A.L.3    Nutt, D.J.4
  • 73
    • 84859426428 scopus 로고    scopus 로고
    • Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline{ballot box} binding site
    • Tyacke RJ, Fisher A, Robinson ESJ, Grundt P, Turner EM, Husbands SM et al. Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline{ballot box} binding site. Synapse. 2012;66(6):542-51.
    • (2012) Synapse , vol.66 , Issue.6 , pp. 542-551
    • Tyacke, R.J.1    Fisher, A.2    Robinson, E.S.J.3    Grundt, P.4    Turner, E.M.5    Husbands, S.M.6
  • 74
    • 79960336672 scopus 로고    scopus 로고
    • In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester
    • Shukuri M, Takashima-Hirano M, Tokuda K, Takashima T, Matsumura K, Inoue O et al. In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester. J Nucl Med. 2011;52(7):1094-101.
    • (2011) J Nucl Med , vol.52 , Issue.7 , pp. 1094-1101
    • Shukuri, M.1    Takashima-Hirano, M.2    Tokuda, K.3    Takashima, T.4    Matsumura, K.5    Inoue, O.6
  • 75
    • 84855369203 scopus 로고    scopus 로고
    • Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: A multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG
    • Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B et al. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med. 2012;53(1):37-46.
    • (2012) J Nucl Med , vol.53 , Issue.1 , pp. 37-46
    • Carter, S.F.1    Schöll, M.2    Almkvist, O.3    Wall, A.4    Engler, H.5    Långström, B.6
  • 77
    • 0038307374 scopus 로고    scopus 로고
    • Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study
    • Versijpt JJ, Dumont F, Van Laere KJ, Decoo D, Santens P, Audenaert K et al. Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study. Eur Neurol. 2003;50(1):39-47.
    • (2003) Eur Neurol , vol.50 , Issue.1 , pp. 39-47
    • Versijpt, J.J.1    Dumont, F.2    van Laere, K.J.3    Decoo, D.4    Santens, P.5    Audenaert, K.6
  • 78
    • 58149305696 scopus 로고    scopus 로고
    • Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation
    • Arlicot N, Katsifis A, Garreau L, Mattner F, Vergote J, Duval S et al. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation. Eur J Nucl Med Mol Imaging. 2008;35(12):2203-11.
    • (2008) Eur J Nucl Med Mol Imaging , vol.35 , Issue.12 , pp. 2203-2211
    • Arlicot, N.1    Katsifis, A.2    Garreau, L.3    Mattner, F.4    Vergote, J.5    Duval, S.6
  • 79
    • 80052566963 scopus 로고    scopus 로고
    • Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation
    • Mattner F, Bandin DL, Staykova M, Berghofer P, Gregoire MC, Ballantyne P et al. Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation. Eur J Nucl Med Mol Imaging. 2011;38(8):1516-28.
    • (2011) Eur J Nucl Med Mol Imaging , vol.38 , Issue.8 , pp. 1516-1528
    • Mattner, F.1    Bandin, D.L.2    Staykova, M.3    Berghofer, P.4    Gregoire, M.C.5    Ballantyne, P.6
  • 81
    • 67449127220 scopus 로고    scopus 로고
    • Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified alpha-linolenic acid in unanesthetized rats
    • Gao F, Kiesewetter D, Chang L, Ma K, Bell JM, Rapoport SI et al. Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified alpha-linolenic acid in unanesthetized rats. J Lipid Res. 2009;50(4):749-58.
    • (2009) J Lipid Res , vol.50 , Issue.4 , pp. 749-758
    • Gao, F.1    Kiesewetter, D.2    Chang, L.3    Ma, K.4    Bell, J.M.5    Rapoport, S.I.6
  • 82
    • 57349111168 scopus 로고    scopus 로고
    • Arachidonic acid and the brain
    • Rapoport SI. Arachidonic acid and the brain. J Nutr. 2008;138(12):2515-20.
    • (2008) J Nutr , vol.138 , Issue.12 , pp. 2515-2520
    • Rapoport, S.I.1
  • 83
    • 77949680686 scopus 로고    scopus 로고
    • Lipid-mediated cell signaling protects against injury and neurodegeneration
    • Zhang C, Bazan NG. Lipid-mediated cell signaling protects against injury and neurodegeneration. J Nutr. 2010;140(4):858-63.
    • (2010) J Nutr , vol.140 , Issue.4 , pp. 858-863
    • Zhang, C.1    Bazan, N.G.2
  • 85
    • 80054857565 scopus 로고    scopus 로고
    • Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity
    • Bazan NG, Musto AE, Knott EJ. Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. Mol Neurobiol. 2011;44(2):216-22.
    • (2011) Mol Neurobiol , vol.44 , Issue.2 , pp. 216-222
    • Bazan, N.G.1    Musto, A.E.2    Knott, E.J.3
  • 86
    • 79960533372 scopus 로고    scopus 로고
    • Docosahexaenoic acid signalolipidomics in nutrition: Significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases
    • Bazan NG, Molina MF, Gordon WC. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr. 2011;31:321-51.
    • (2011) Annu Rev Nutr , vol.31 , pp. 321-351
    • Bazan, N.G.1    Molina, M.F.2    Gordon, W.C.3
  • 87
    • 81155134068 scopus 로고    scopus 로고
    • Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission
    • Rapoport SI, Ramadan E, Basselin M. Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission. Prostaglandins Other Lipid Mediat. 2011;96(1-4):109-13.
    • (2011) Prostaglandins Other Lipid Mediat , vol.96 , Issue.1-4 , pp. 109-113
    • Rapoport, S.I.1    Ramadan, E.2    Basselin, M.3
  • 90
    • 67650529118 scopus 로고    scopus 로고
    • Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography
    • Umhau JC, Zhou W, Carson RE, Rapoport SI, Polozova A, Demar J et al. Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res. 2009;50(7):1259-68.
    • (2009) J Lipid Res , vol.50 , Issue.7 , pp. 1259-1268
    • Umhau, J.C.1    Zhou, W.2    Carson, R.E.3    Rapoport, S.I.4    Polozova, A.5    Demar, J.6
  • 91
    • 0034500422 scopus 로고    scopus 로고
    • Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment
    • Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids. 2000;35(12):1305-12.
    • (2000) Lipids , vol.35 , Issue.12 , pp. 1305-1312
    • Conquer, J.A.1    Tierney, M.C.2    Zecevic, J.3    Bettger, W.J.4    Fisher, R.H.5
  • 92
    • 78049407029 scopus 로고    scopus 로고
    • Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial
    • Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304(17):1903-11.
    • (2010) JAMA , vol.304 , Issue.17 , pp. 1903-1911
    • Quinn, J.F.1    Raman, R.2    Thomas, R.G.3    Yurko-Mauro, K.4    Nelson, E.B.5    van Dyck, C.6
  • 93
    • 0032542958 scopus 로고    scopus 로고
    • Fish consumption and major depression
    • Hibbeln JR. Fish consumption and major depression. Lancet. 1998;351(9110):1213.
    • (1998) Lancet , vol.351 , Issue.9110 , pp. 1213
    • Hibbeln, J.R.1
  • 94
    • 79952456012 scopus 로고    scopus 로고
    • 11 C] enzastaurin, the first design and radiosynthesis of a new potential PET agent for imaging of protein kinase C
    • 11 C] enzastaurin, the first design and radiosynthesis of a new potential PET agent for imaging of protein kinase C. Bioorg Med Chem Lett. 2011;21(6):1649-53.
    • (2011) Bioorg Med Chem Lett , vol.21 , Issue.6 , pp. 1649-1653
    • Wang, M.1    Xu, L.2    Gao, M.3    Miller, K.D.4    Sledge G.W.Zheng, Q.-H.5
  • 95
    • 67749147448 scopus 로고    scopus 로고
    • Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's diseasethat decreases Abeta production while blocking oxidative stress
    • Kozikowski AP, Chen Y, Subhasish T, Lewin NE, Blumberg PM, Zhong Z et al. Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's diseasethat decreases Abeta production while blocking oxidative stress. ChemMedChem. 2009;4(7):1095-105.
    • (2009) ChemMedChem , vol.4 , Issue.7 , pp. 1095-1105
    • Kozikowski, A.P.1    Chen, Y.2    Subhasish, T.3    Lewin, N.E.4    Blumberg, P.M.5    Zhong, Z.6
  • 96
    • 78649449000 scopus 로고    scopus 로고
    • A novel PET marker for in vivo quantification of myelination
    • Wu C, Wang C, Popescu DC, Zhu W, Somoza EA, Zhu J et al. A novel PET marker for in vivo quantification of myelination. Bioorg Med Chem. 2010;18(24):8592-9.
    • (2010) Bioorg Med Chem , vol.18 , Issue.24 , pp. 8592-8599
    • Wu, C.1    Wang, C.2    Popescu, D.C.3    Zhu, W.4    Somoza, E.A.5    Zhu, J.6
  • 97
    • 79956198149 scopus 로고    scopus 로고
    • Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease
    • Lassmann H. Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease. J Neural Transm. 2011;118(5):747-52.
    • (2011) J Neural Transm , vol.118 , Issue.5 , pp. 747-752
    • Lassmann, H.1
  • 98
    • 75149142186 scopus 로고    scopus 로고
    • Hsp70 molecular chaperones and Parkinson's disease
    • Witt SN. Hsp70 molecular chaperones and Parkinson's disease. Biopolymers. 2010;93(3):218-28.
    • (2010) Biopolymers , vol.93 , Issue.3 , pp. 218-228
    • Witt, S.N.1
  • 99
    • 0032576605 scopus 로고    scopus 로고
    • Aggresomes: A cellular response to misfolded proteins
    • Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol. 1998;143(7):1883-98.
    • (1998) J Cell Biol , vol.143 , Issue.7 , pp. 1883-1898
    • Johnston, J.A.1    Ward, C.L.2    Kopito, R.R.3
  • 100
    • 84861213255 scopus 로고    scopus 로고
    • Cathepsins L and Z Are Critical in Degrading Polyglutaminecontaining Proteins within Lysosomes
    • Bhutani N, Piccirillo R, Hourez R, Venkatraman P, Goldberg AL. Cathepsins L and Z Are Critical in Degrading Polyglutaminecontaining Proteins within Lysosomes. J Biol Chem. 2012;287(21):17471-82.
    • (2012) J Biol Chem , vol.287 , Issue.21 , pp. 17471-17482
    • Bhutani, N.1    Piccirillo, R.2    Hourez, R.3    Venkatraman, P.4    Goldberg, A.L.5
  • 101
    • 84857315582 scopus 로고    scopus 로고
    • Monitoring the induction of heat shock factor 1/ heat shock protein 70 expression following 17-allylaminodemethoxygeldanamycin treatment by positron emission tomography and optical reporter gene imaging
    • Doubrovin M, Che JT, Serganova I, Moroz E, Solit DB, Ageyeva L et al. Monitoring the induction of heat shock factor 1/ heat shock protein 70 expression following 17-allylaminodemethoxygeldanamycin treatment by positron emission tomography and optical reporter gene imaging. Mol Imaging. 2012;11(1):67-76.
    • (2012) Mol Imaging , vol.11 , Issue.1 , pp. 67-76
    • Doubrovin, M.1    Che, J.T.2    Serganova, I.3    Moroz, E.4    Solit, D.B.5    Ageyeva, L.6
  • 102
    • 84865563936 scopus 로고    scopus 로고
    • Hematopoietic MyD88-adaptor Protein Acts as a Natural Defense Mechanism for Cognitive Deficits in Alzheimer's Disease
    • Available at, cited 2012 May 17
    • Michaud J-P, Richard KL, Rivest S. Hematopoietic MyD88-adaptor Protein Acts as a Natural Defense Mechanism for Cognitive Deficits in Alzheimer's Disease. Stem Cell Rev [Available at: http://www.ncbi.nlm.nih.gov/pubmed/22374079]. 2012 [cited 2012 May 17].
    • (2012) Stem Cell Rev
    • Michaud, J.-P.1    Richard, K.L.2    Rivest, S.3
  • 103
    • 79960282591 scopus 로고    scopus 로고
    • The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity
    • Côté M, Drouin-Ouellet J, Cicchetti F, Soulet D. The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity. Brain Behav Immun. 2011;25(6):1143-52.
    • (2011) Brain Behav Immun , vol.25 , Issue.6 , pp. 1143-1152
    • Côté, M.1    Drouin-Ouellet, J.2    Cicchetti, F.3    Soulet, D.4
  • 105
    • 84859598872 scopus 로고    scopus 로고
    • Biology of mitochondria in neurodegenerative diseases
    • Martin LJ. Biology of mitochondria in neurodegenerative diseases. Prog Mol Biol Transl Sci. 2012;107:355-415.
    • (2012) Prog Mol Biol Transl Sci , vol.107 , pp. 355-415
    • Martin, L.J.1
  • 106
    • 84857116578 scopus 로고    scopus 로고
    • Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
    • Ray PD, Huang B-W, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24(5):981-90.
    • (2012) Cell Signal , vol.24 , Issue.5 , pp. 981-990
    • Ray, P.D.1    Huang, B.-W.2    Tsuji, Y.3
  • 107
    • 84863761145 scopus 로고    scopus 로고
    • Radiolabelled Agents for PET Imaging of Tumor Hypoxia
    • Available at, cited 2012 Jun 11
    • Kurihara H, Honda N, Kono Y, Arai Y. Radiolabelled Agents for PET Imaging of Tumor Hypoxia. Curr Med Chem [Available at: http://www.ncbi.nlm.nih.gov/pubmed/22664246]. 2012 [cited 2012 Jun 11].
    • (2012) Curr Med Chem
    • Kurihara, H.1    Honda, N.2    Kono, Y.3    Arai, Y.4
  • 108
    • 80053605315 scopus 로고    scopus 로고
    • Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET
    • Ikawa M, Okazawa H, Kudo T, Kuriyama M, Fujibayashi Y, Yoneda M. Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET. Nucl Med Biol. 2011;38(7):945-51.
    • (2011) Nucl Med Biol , vol.38 , Issue.7 , pp. 945-951
    • Ikawa, M.1    Okazawa, H.2    Kudo, T.3    Kuriyama, M.4    Fujibayashi, Y.5    Yoneda, M.6
  • 109
    • 84856333052 scopus 로고    scopus 로고
    • Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: Studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation
    • Yoshii Y, Yoneda M, Ikawa M, Furukawa T, Kiyono Y, Mori T et al. Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation. Nucl Med Biol. 2012;39(2):177-85.
    • (2012) Nucl Med Biol , vol.39 , Issue.2 , pp. 177-185
    • Yoshii, Y.1    Yoneda, M.2    Ikawa, M.3    Furukawa, T.4    Kiyono, Y.5    Mori, T.6
  • 110
    • 0038241171 scopus 로고    scopus 로고
    • Polymorphism in the P-glycoprotein drug transporter MDR1 gene: A possible link between environmental and genetic factors in Parkinson's disease
    • Droździk M, Biatecka M, Myśliwiec K, Honczarenko K, Stankiewicz J, Sych Z. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics. 2003;13(5):259-63.
    • (2003) Pharmacogenetics , vol.13 , Issue.5 , pp. 259-263
    • Droździk, M.1    Biatecka, M.2    Myśliwiec, K.3    Honczarenko, K.4    Stankiewicz, J.5    Sych, Z.6
  • 112
    • 0036797713 scopus 로고    scopus 로고
    • Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans
    • Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W et al. Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics. 2002;12(7):535-41.
    • (2002) Pharmacogenetics , vol.12 , Issue.7 , pp. 535-541
    • Vogelgesang, S.1    Cascorbi, I.2    Schroeder, E.3    Pahnke, J.4    Kroemer, H.K.5    Siegmund, W.6
  • 113
    • 70049084419 scopus 로고    scopus 로고
    • Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration
    • Bartels AL, Kortekaas R, Bart J, Willemsen ATM, de Klerk OL, de Vries JJ et al. Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol Aging. 2009;30(11):1818-24.
    • (2009) Neurobiol Aging , vol.30 , Issue.11 , pp. 1818-1824
    • Bartels, A.L.1    Kortekaas, R.2    Bart, J.3    Willemsen, A.T.M.4    de Klerk, O.L.5    de Vries, J.J.6
  • 115
    • 84860344567 scopus 로고    scopus 로고
    • Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease
    • Donovan LE, Higginbotham L, Dammer EB, Gearing M, Rees HD, Xia Q et al. Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease. Proteomics Clin Appl. 2012;6(3-4):201-11.
    • (2012) Proteomics Clin Appl , vol.6 , Issue.3-4 , pp. 201-211
    • Donovan, L.E.1    Higginbotham, L.2    Dammer, E.B.3    Gearing, M.4    Rees, H.D.5    Xia, Q.6
  • 116
    • 77953068390 scopus 로고    scopus 로고
    • Synergistic Interactions between Abeta, tau, and alphasynuclein: Acceleration of neuropathology and cognitive decline
    • Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM. Synergistic Interactions between Abeta, tau, and alphasynuclein: acceleration of neuropathology and cognitive decline. J Neurosci. 2010;30(21):7281-9.
    • (2010) J Neurosci , vol.30 , Issue.21 , pp. 7281-7289
    • Clinton, L.K.1    Blurton-Jones, M.2    Myczek, K.3    Trojanowski, J.Q.4    Laferla, F.M.5
  • 117
    • 84877987417 scopus 로고    scopus 로고
    • Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come?
    • Available at, cited 2012 Jun 22
    • Zetterberg H, Blennow K. Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come? J Alzheimers Dis [Available at: http://www.ncbi.nlm.nih.gov/pubmed/22710917]. 2012 [cited 2012 Jun 22].
    • (2012) J Alzheimers Dis
    • Zetterberg, H.1    Blennow, K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.